Epidemiology of oesophagogastric cancer

Best Practice and Research: Clinical Gastroenterology

Volumn 21, Issue 6, 2007, Pages 921-945

  Lambert, R ^a   Hainaut, P ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Barrett's oesophagus; endoscopy; epidemiology; Helicobacter pylori; oesophageal cancer; stomach cancer

Indexed keywords

ACETYLSALICYLIC ACID; ALKALOID; ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; ASCORBIC ACID; BETA CAROTENE; CARCINOGEN; CYCLOOXYGENASE 2 INHIBITOR; MYCOTOXIN; NITRATE; NITRITE; NITROSAMINE; RETINOL;

ADENOCARCINOMA; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; ASIA; ATROPHIC GASTRITIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER SCREENING; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL TRIAL; EARLY DIAGNOSIS; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOGASTRIC ADENOCARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEREDITY; HISTOPATHOLOGY; HUMAN; INFLAMMATION; JAPAN; LIFESTYLE; NUTRITIONAL DEFICIENCY; PATHOLOGICAL ANATOMY; PRIMARY PREVENTION; REFLUX ESOPHAGITIS; SMOKING; SOCIOECONOMICS; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; STOMACH MUCOSA; CELL TRANSFORMATION; ESOPHAGUS TUMOR; INCIDENCE; LOWER ESOPHAGUS SPHINCTER; PATHOLOGY; PRECANCER; REVIEW; RISK FACTOR; STOMACH TUMOR;

ADENOCARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; HUMANS; INCIDENCE; NEOPLASMS, SQUAMOUS CELL; PRECANCEROUS CONDITIONS; RISK FACTORS; STOMACH NEOPLASMS;

EID: 36749031647     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2007.10.001     Document Type: Article

References (58)

1. Ferlay F., Bray P., Pisani, et al. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5, version 2.0 (2004), IARC Press, Lyon
2. Lambert R., Hainaut P., and Parkin D.M. Premalignant lesions of the esophagogastric mucosa. Semin Oncol 31 (2004) 498-512
3. Paris workshop on columnar metaplasia in the esophagus and the esophagogastric junction, Paris, France, December 11-12 2004. Endoscopy 37 (2005) 879-920
4. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon. Gastrointest Endosc 58 Suppl. 6 (2003) S3-S43
5. Takubo K., Arai T., Sawabe M., et al. Structures of the normal esophagus and Barrett's esophagus. Esophagus 1 (2003) 37-47
6. Taniere P., Borghi-Scoazec G., Saurin J.C., et al. Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of adenocarcinomas of the distal esophagus and of the proximal stomach. Am J Surg Pathol 26 (2002) 1213-1221
7. Parkin D.M., Whelan S.L., Ferlay J., et al. Cancer incidence in five continents (2002), IARC Press, Lyon IARC Publ. No. 155
8. Lambert R., and Hainaut P. Esophageal cancer. II. The precursors. Endoscopy 39 (2007) 659-664
9. Dixon M.F. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut 51 (2002) 130-131
10. Tsukuma H., Mishima T., and Oshima A. Prospective study of 'early' gastric cancer. Int J Cancer 31 (1983) 421-426
11. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on cancer epidemiology and prevention. Cancer Res 52 (1992) 6735-6740
12. Mandard A.M., Hainaut P., and Hollstein M. Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res 462 (2000) 335-342
13. Mandard A.M., Marnav J., Lebeau C., et al. Expression of p53 in oesophageal squamous epithelium from surgical specimens resected for squamous cell carcinoma of the oesophagus, with special reference to uninvolved mucosa. J Pathol 18 (1997) 153-157
14. Taniere P., Martel-Plache G., Saurin J.C., et al. TP53 mutations, amplification of P63 and expression of cell cycle proteins in squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe. Br J Cancer 85 (2001) 721-726
15. Daniely Y., Yao G., Dixon D., et al. Critical role of p63 in the development of a normal esophageal and tracheobronchial epithelium. Am J Physiol Cell Physiol 287 (2004) C171-C181
16. Levrero M., De Laurenzi V., Costanzo A., et al. The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J Cell Sci 113 (2000) 1661-1670
17. Morita M., Uramoto H., Ono K., et al. Expression of deltaNp63 in squamous cell carcinoma of the esophagus. Anticancer Res 25 (2005) 3533-3539
18. Hall P.A., Woodman A.C., Campbell S.J., et al. Expression of the p53 homologue p63alpha and DeltaNp63alpha in the neoplastic sequence of Barrett's oesophagus: correlation with morphology and p53 protein. Gut 49 (2001) 618-623
19. Taniere P., Martel-Planche G., Maurici D., et al. Molecular and clinical differences between adenocarcinomas of the esophagus and of the gastric cardia. Am J Pathol 158 (2001) 33-40
20. Lambert R., and Hainaut P. Esophageal cancer. I. Cases and causes. Endoscopy 39 (2007) 550-555
21. Jacob J.H., Riviere A., Mandard A.M., et al. Prevalence survey of precancerous lesions of the oesophagus in a high-risk population for oesophageal cancer in France. Eur J Cancer Prev 2 (1993) 53-59
22. Zhengzhou university international symposium on esophageal cancer, August 27-30 2005. Proceedings (unpublished data).
23. Ke L. Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970-90. Int J Cancer 102 (2002) 271-274
24. He Y.T., Hou J., and Qiao C.Y. An analysis of esophageal cancer incidence in Cixian county from 1974 to 1996. World J Gastroenterol 9 (2003) 209-213
25. Tian J., and Chen J.S. Time trends of incidence of digestive system cancers in Changle of China during 1988-2002. World J Gastroenterol 12 (2006) 4569-4771
26. Dawsey S.M., Lewin K.J., Wang G.Q., et al. Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus. A prospective follow-up study from Linxian, China. Cancer 74 (1994) 1686-1692
27. Munoz N., Crespi M., Grassi A., et al. Precursor lesions of oesophageal cancer in high-risk populations in Iran and China. Lancet 1 (1982) 876-879
28. Munoz N., and Crespi M. Esophageal morphology from Linxian, China: squamous histologic findings in 754 patients. Cancer 75 (1995) 2779-2781
29. Wang G.Q., Abnet C.C., Shen Q., et al. Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population. Gut 54 (2005) 187-192
30. Dai M., Zhang W.-D., Clifford G.M., et al. Human papillomavirus infection among 100 oesophageal cancer cases in the People's Republic of China. Int J Cancer 121 (2007) 1396-1398
31. Jaskiewicz K., Venter F.S., and Marasas W.F. Cytopathology of the esophagus in Transkei. J Natl Cancer Inst 79 (1987) 961-967
32. Parkin M, Munoz M, Vizcaino P. Incidence time trends for cancers of the lung, esophagus and gastric cardia by histological type in the European community 1973-93. Contract No. 97/CAN/33850, Final report to EU, Brussels, 2000.
33. Vizcaino A.P., Moreno V., Lambert R., et al. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer 99 (2002) 860-888
34. Devesa S.S., Blot W.J., and Fraumeni J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83 (1998) 2049-2053
35. Powell J., and McConkey C.C. The rising trend in oesophageal adenocarcinoma and gastric cardia. Eur J Cancer Prev 1 (1992) 265-269
36. Siewert J.R., Stein H.J., and Feith M. Surgical approach to invasive adenocarcinoma of the distal esophagus (Barrett's cancer). World J Surg 27 (2003) 1058-1061
37. Zheng T., Mayne S.T., Holford T.R., et al. The time trend and age-period-cohort effects on incidence of adenocarcinoma of the stomach in Connecticut from 1955-1989. Cancer 72 (1993) 330-340
38. Osaka Cancer Registry. Survival of cancer patients in Osaka (1975-89) (1998), Shinohara Publ., Tokyo
39. Report on health center activities and health services for the aged (2003), Ministry of Health, Labour and Welfare of Japan pp. 550-554
40. Cancer statistics in Japan. Foundation for promotion of cancer research (2005), National Cancer Center, Tokyo
41. SEER cancer incidence public use database. SEER cancer statistics review. Bethesda: National Cancer Institute. Available from: http://www.seer.cancer.gov/.
42. Coleman M.P., Gatta G., Verdecchia A., et al., EUROCARE Working Group. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 14 Suppl. 5 (2003) 128-149. http://www.eurocare.it Available from:
43. Lee C.H., Wu D.C., Lee J.M., et al. Carcinogenetic impact of alcohol intake on squamous cell carcinoma risk of the oesophagus in relation to tobacco smoking. Eur J Cancer (2007) 23 [Epub ahead of print]
44. Ronkainen J., Aro P., Storzkrubb T., et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 129 (2005) 1825-1831
45. Roman S., Petre A., Thepot A., et al. Down-regulation of p63 upon exposure to bile salts and acid in normal and cancer esophageal cells in culture. Am J Physiol 293 (2007) G45-G53
46. Lambert R., and Parkin D.M. Screening, surveillance & prevention of gastric cancer. In: Kelsen D.H., Daly J.M., Kern S.E., et al. (Eds). Gastrointestinal oncology (2002), Lippincott Williams Wilkins 341-354
47. Parkin D.M. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118 (2006) 3030-3044
48. EUROGAST. Epidemiology of stomach cancer and risk factors for Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group. Gut 34 (1993) 1672-1676
49. Labenz J., Jaspersen D., Kulig M., et al. Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol 99 (2004) 1652-1656
50. Spechler S.J. Barrett's esophagus: an overrated cancer risk factor. Gastroenterology 119 (2000) 587-589
51. Reid B.J., Blount P.L., and Rabinovitch P.S. Biomarkers in Barrett's esophagus. Gastrointest Endosc Clin N Am 13 (2003) 369-397
52. van der Burgh A., Dees J., Hop W.C.J., et al. Oesophageal cancer is an uncommon cause of death in patients with Barrett's esophagus. Gut 39 (1996) 5-8
53. Schistosomes, liver flukes and Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans vol. 61 (1994), International Agency for Research on Cancer, Lyon pp. 177-240
54. Tomb J.F., White O., Kerlavage A.R., et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 388 (1997) 539-547
55. Yokoyama T., Yokoyama A., Kato H., et al. Alcohol flushing, alcohol and aldehyde dehydrogenase genotypes, and risk for esophageal squamous cell carcinoma in Japanese men. Cancer Epidemiol Biomarkers Prev 12 (2003) 1227-1233
56. Lambert R., Saito H., and Saito Y. High-resolution endoscopy and early digestive cancer. Endoscopy 39 (2007) 232-237
57. A nationwide totalling of mass screening for gastrointestinal cancers in 2002. J Gastroenterol Mass Survey 43 (2005) 54-73 [in Japanese]
58. Yoshihara M., Sumii K., Haruma K., et al. The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography. Hiroshima J Med Sci 46 (1997) 81-86